CellWell record HH-140942
Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond
Nahed S Alharthi
2026
In plain language
This review describes how diabetes-related metabolic disturbances, including hyperglycemia and insulin resistance, share molecular pathways such as PI3K/AKT/mTOR with cancer development and progression.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-140942
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.